Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $77,435 | 28 | 89.1% |
| Food and Beverage | $9,443 | 650 | 10.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.0% |
| Education | $14.80 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CapsoVision, Inc. | $77,435 | 28 | $0 (2024) |
| ABBVIE INC. | $2,936 | 217 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $991.83 | 78 | $0 (2024) |
| Janssen Biotech, Inc. | $835.53 | 54 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $751.93 | 50 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $549.83 | 33 | $0 (2024) |
| PFIZER INC. | $353.24 | 22 | $0 (2024) |
| Braintree Laboratories, Inc. | $319.40 | 23 | $0 (2024) |
| Celgene Corporation | $290.07 | 22 | $0 (2024) |
| Allergan Inc. | $247.47 | 22 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37,073 | 113 | CapsoVision, Inc. ($35,318) |
| 2023 | $20,849 | 103 | CapsoVision, Inc. ($19,345) |
| 2022 | $14,571 | 120 | CapsoVision, Inc. ($13,000) |
| 2021 | $10,349 | 55 | CapsoVision, Inc. ($9,772) |
| 2020 | $367.70 | 26 | Janssen Biotech, Inc. ($104.45) |
| 2019 | $1,039 | 80 | AbbVie, Inc. ($241.02) |
| 2018 | $1,217 | 93 | AbbVie, Inc. ($340.89) |
| 2017 | $1,447 | 90 | AbbVie, Inc. ($435.00) |
All Payment Transactions
680 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | CapsoVision, Inc. | CapsoCam Colon (Device) | Consulting Fee | Cash or cash equivalent | $4,950.00 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: GI | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: GI COLON PREP | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Boston Scientific Corporation | CRE PRO (Device) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: CRE_ENDO | ||||||
| 11/22/2024 | CapsoVision, Inc. | CapsoCam Colon (Device) | Consulting Fee | Cash or cash equivalent | $2,673.00 | General |
| Category: Gastroenterology | ||||||
| 11/21/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.47 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Immunology | ||||||
| 11/16/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: GI | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.87 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | CapsoVision, Inc. | CapsoCam Colon (Device) | Consulting Fee | Cash or cash equivalent | $8,390.25 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 336 | 375 | $316,050 | $40,992 |
| 2022 | 9 | 396 | 456 | $321,477 | $43,413 |
| 2021 | 10 | 404 | 492 | $220,344 | $48,666 |
| 2020 | 9 | 301 | 400 | $158,733 | $35,109 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 108 | $37,692 | $10,817 | 28.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 45 | 45 | $85,388 | $9,958 | 11.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 45 | 45 | $81,675 | $5,045 | 6.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $14,520 | $4,069 | 28.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 42 | 42 | $66,990 | $3,506 | 5.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 17 | 31 | $7,130 | $2,146 | 30.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 31 | $7,285 | $1,965 | 27.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $8,800 | $1,778 | 20.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $6,570 | $1,707 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 119 | $40,145 | $10,930 | 27.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 31 | 31 | $56,693 | $6,317 | 11.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 51 | 53 | $93,265 | $5,704 | 6.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $21,000 | $5,066 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 66 | $14,915 | $4,362 | 29.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 40 | 43 | $65,613 | $3,585 | 5.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 36 | 36 | $12,570 | $2,977 | 23.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 23 | 23 | $9,578 | $2,514 | 26.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 36 | $7,698 | $1,959 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 141 | $27,495 | $14,215 | 51.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 57 | 57 | $17,100 | $7,797 | 45.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 29 | 29 | $39,845 | $6,403 | 16.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 48 | 49 | $63,132 | $5,342 | 8.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 44 | 47 | $44,044 | $4,144 | 9.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 36 | 66 | $10,032 | $4,122 | 41.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 26 | 26 | $8,164 | $2,955 | 36.2% |
About Dr. Amy Shriver, M.D
Dr. Amy Shriver, M.D is a Gastroenterology healthcare provider based in Princeton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/09/2009. The National Provider Identifier (NPI) number assigned to this provider is 1164665998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Shriver, M.D has received a total of $86,913 in payments from pharmaceutical and medical device companies, with $37,073 received in 2024. These payments were reported across 680 transactions from 44 companies. The most common payment nature is "Consulting Fee" ($77,435).
As a Medicare-enrolled provider, Shriver has provided services to 1,437 Medicare beneficiaries, totaling 1,723 services with total Medicare billing of $168,180. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Princeton, NJ
- Active Since 04/09/2009
- Last Updated 07/27/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1164665998
Products in Payments
- CapsoCam Colon (Device) $77,435
- XIFAXAN (Drug) $803.35
- STELARA (Biological) $711.05
- Humira (Biological) $693.40
- RINVOQ (Biological) $643.36
- SKYRIZI (Biological) $603.59
- Linzess (Drug) $439.99
- ENTYVIO (Biological) $436.47
- HUMIRA (Biological) $331.56
- XELJANZ (Drug) $319.45
- Entyvio (Biological) $294.83
- ZEPOSIA (Drug) $290.07
- LINZESS (Drug) $271.23
- ZENPEP (Drug) $200.35
- Cimzia (Drug) $189.90
- RELISTOR ORAL (Drug) $170.09
- DIFICID (Drug) $167.61
- UCERIS (Drug) $138.36
- VIBERZI (Drug) $137.94
- OMVOH (Drug) $136.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Princeton
Dr. Anish Sheth, Md, MD
Gastroenterology — Payments: $205,196
Glenn Osias, Md, MD
Gastroenterology — Payments: $13,027
Aaron Bellows, M.d, M.D
Gastroenterology — Payments: $7,850
Robert Meirowitz, Md, MD
Gastroenterology — Payments: $7,725
Aloysius Rho, Md, MD
Gastroenterology — Payments: $7,329
Dr. Darren Andrade, M.d, M.D
Gastroenterology — Payments: $5,859